Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
- 30 October 2006
- journal article
- Published by Elsevier
- Vol. 25 (15) , 2832-2838
- https://doi.org/10.1016/j.vaccine.2006.10.031
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccinesVirology, 2006
- A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in miceVaccine, 2006
- Vaccine Design for Severe Acute Respiratory Syndrome CoronavirusViral Immunology, 2005
- Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding RegionJournal of Virology, 2005
- Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronavirusesProceedings of the National Academy of Sciences, 2005
- Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in miceVaccine, 2004
- Mucosal immunisation of African green monkeys ( Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARSThe Lancet, 2004
- Mounting Lab Accidents Raise SARS FearsScience, 2004
- Real-Time Polymerase Chain Reaction for Detecting SARS Coronavirus, Beijing, 2003Emerging Infectious Diseases, 2004
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern ChinaScience, 2003